Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q


ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2003

OR


o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                               TO                              

Commission File Number 0-22660


TRIQUINT SEMICONDUCTOR, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware   95-3654013
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer Identification No.)

2300 NE Brookwood Parkway
Hillsboro, OR 97124
(Address of Principal Executive Offices) (Zip Code)

(503) 615-9000
(Registrant's Telephone Number, Including Area Code)


        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o

        Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes ý    No o

        As of June 30, 2003, there were 134,166,266 shares of the registrant's common stock outstanding.





TRIQUINT SEMICONDUCTOR, INC.

INDEX

PART I.

  FINANCIAL INFORMATION
  PAGE NO.
Item 1.   Financial Statements   3

 

 

Condensed Consolidated Statements of Operations—Three and six months ended June 30, 2003 and 2002

 

3

 

 

Condensed Consolidated Balance Sheets—June 30, 2003 and December 31, 2002

 

4

 

 

Condensed Consolidated Statements of Cash Flows—Six months ended June 30, 2003 and 2002

 

5

 

 

Notes to Condensed Consolidated Financial Statements

 

6

Item 2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

15

Item 3.

 

Qualitative and Quantitative Disclosures about Market and Interest Rate Risk

 

42

Item 4.

 

Controls and Procedures

 

43


PART II.



 


OTHER INFORMATION



 


 


Item 1.

 

Legal Proceedings

 

44

Item 4.

 

Submission of Matters to a Vote of Security Holders

 

44

Item 6.

 

Exhibits and Reports on Form 8-K

 

45

SIGNATURES

 

46

2



PART I—FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS


TRIQUINT SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share amounts)

(Unaudited)

 
  Three Months Ended
  Six Months Ended
 
 
  June 30,
2003

  June 30,
2002

  June 30,
2003

  June 30,
2002

 
Revenues   $ 72,815   $ 61,232   $ 144,470   $ 123,583  
Cost of goods sold     54,090     38,916     109,822     80,210  
   
 
 
 
 
  Gross profit     18,725     22,316     34,648     43,373  
Operating expenses:                          
  Research, development and engineering     17,702     12,201     35,062     25,441  
  Selling, general and administrative     14,404     10,671     27,415     21,358  
  In-process research and development             500      
  Severance costs     2,643         2,793      
  Lease termination costs     41,962         41,962      
   
 
 
 
 
    Total operating expenses     76,711     22,872     107,732     46,799  
   
 
 
 
 
    Loss from operations     (57,986 )   (556 )   (73,084 )   (3,426 )
   
 
 
 
 
Other income (expense):                          
  Interest income     1,635     3,007     3,489     6,073  
  Interest expense     (3,023 )   (3,259 )   (6,027 )   (6,598 )
  Other, net     (139 )   4,130     (286 )   4,537  
   
 
 
 
 
    Total other income (expense), net     (1,527 )   3,878     (2,824 )   4,012  
   
 
 
 
 
    Income (loss) before income tax     (59,513 )   3,322     (75,908 )   586  
Income tax expense     47     899     167     351  
   
 
 
 
 
    Net income (loss)   $ (59,560 ) $ 2,423   $ (76,075 ) $ 235  
   
 
 
 
 

Per share data:

 

 

 

 

 

 

 

 

 

 

 

 

 
    Basic net income (loss)   $ (0.45 ) $ 0.02   $ (0.57 ) $ 0.00  
   
 
 
 
 
    Weighted-average common shares     133,554,233     131,656,161     133,374,070     131,470,021  
   
 
 
 
 
    Diluted net income (loss)   $ (0.45 ) $ 0.02   $ (0.57 ) $ 0.00  
   
 
 
 
 
    Weighted-average common and common equivalent shares     133,554,233     134,843,992     133,374,070     134,891,614  
   
 
 
 
 

See Notes to Condensed Consolidated Financial Statements

3



TRIQUINT SEMICONDUCTOR, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 
  June 30,
2003

  December 31,
2002(1)

 
Assets              
Current assets:              
  Cash and cash equivalents   $ 263,750   $ 226,226  
  Investments in marketable securities     57,269     109,687  
  Accounts receivable, net     40,576     34,977  
  Inventories, net     58,048     36,283  
  Other current assets     9,188     9,621  
  Assets held for sale     24,505      
   
 
 
    Total current assets     453,336     416,794  
   
 
 

Long-term investments in marketable securities

 

 

80,268

 

 

131,127

 
Property, plant and equipment, net     168,373     153,887  
Other investment     46,131     88,092  
Restricted long-term assets     17,408     17,408  
Other non-current assets, net     34,862     33,358  
   
 
 
    Total assets   $ 800,378   $ 840,666  
   
 
 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 
Current liabilities:              
  Current installments of capital lease and installment note obligations   $   $ 341  
  Accounts payable and accrued expenses     71,358     39,348  
   
 
 
    Total current liabilities     71,358     39,689  
Deferred income taxes     6,572     6,550  
Long-term debt and other liabilities, less current installments     269,574     268,755  
   
 
 
    Total liabilities     347,504     314,994  
   
 
 

Stockholders' equity:

 

 

 

 

 

 

 
  Common stock     456,435     452,894  
  Accumulated other comprehensive income     397     661  
  Unearned ESOP compensation     (195 )   (195 )
  Retained earnings (accumulated deficit)     (3,763 )   72,312  
   
 
 
    Total stockholders' equity     452,874     525,672  
   
 
 
    Total liabilities and stockholders' equity   $ 800,378   $ 840,666  
   
 
 

(1)
The information in this column was derived from the Company's audited consolidated financial statements as of December 31, 2002.

See Notes to Condensed Consolidated Financial Statements

4



TRIQUINT SEMICONDUCTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 
  Six Months Ended
 
 
  June 30,
2003

  June 30,
2002

 
Cash flows from operating activities:              
  Net income (loss)   $ (76,075 ) $ 235  
  Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:              
    Depreciation and amortization     18,534     17,374  
    Deferred income taxes     22      
    Acquired in-process research and development     500      
    Income tax benefit of stock option exercises         980  
    Lease termination costs     41,962      
    Loss on disposal of assets     209     391  
    Gain on extinguishment of debt         (2,298 )
    Loss on investments         3,242  
    Unrealized gain on forward contract         (4,570 )
    Changes in assets and liabilities, net of assets acquired:              
    (Increase) decrease in:              
      Accounts receivable     (5,707 )   1,504  
      Inventories     (9,765 )   4,985  
      Prepaid expenses and other assets     1,190     4,618  
    Increase (decrease) in:              
      Accounts payable and accrued expenses     10,080     (5,159 )
   
 
 
    Net cash provided by (used in) operating activities     (19,050 )   21,302  

Cash flows from investing activities:

 

 

 

 

 

 

 
  Purchase of available-for-sale investments     (212,927 )   (233,681 )
  Maturity/sale of available-for-sale investments     315,939     283,314  
  Advances to or investment in other companies         (5,996 )
  Business acquisition costs     (40,151 )   (427 )
  Proceeds from sale of assets     10,242      
  Capital expenditures     (19,729 )   (27,699 )
   
 
 
    Net cash provided by investing activities     53,374     15,511  

Cash flows from financing activities:

 

 

 

 

 

 

 
  Principal payments under capital lease obligations     (341 )   (1,185 )
  Repurchase of convertible subordinated notes         (9,435 )
  Issuance of common stock, net     3,541     4,682  
   
 
 
    Net cash provided by (used in) financing activities     3,200     (5,938 )
   
Net increase in cash and cash equivalents

 

 

37,524

 

 

30,875

 
Cash and cash equivalents at the beginning of the period     226,226     261,728  
   
 
 
Cash and cash equivalents at the end of the period   $ 263,750   $ 292,603  
   
 
 

See Notes to Condensed Consolidated Financial Statements

5



TRIQUINT SEMICONDUCTOR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands unless noted otherwise, except share and per share amounts)

(Unaudited)

        1.    Basis of Presentation and Significant Accounting Policies    

        The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. However, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). In the opinion of management, the statements include all adjustments necessary (which are of a normal and recurring nature) for the fair presentation of the results of the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the audited financial statements of TriQuint Semiconductor, Inc. (the "Company") for the fiscal year ended December 31, 2002, as included in the Company's 2002 Annual Report on Form 10-K as filed with the SEC on March 27, 2003.

        The Company's fiscal quarters end on the Saturday nearest the end of the calendar quarter. For convenience, the Company has indicated that its second quarter ended on June 30. The Company's fiscal year ends on December 31.

Foreign Currency Exchange and Remeasurement

        The Company's functional currency for all operations worldwide is the U.S. dollar. For foreign operations with the U.S. dollar as the functional currency, monetary assets and liabilities are remeasured at the period-end exchange rates. Certain non-monetary assets and liabilities are remeasured using historical rates. Statements of operations are remeasured at an average exchange rate for the period. Foreign currency gains and losses resulting from remeasurement or settlement of receivables and payables denominated in a currency other than the functional currency are included in "Other income (expense)".

Investments in Marketable Securities

        The Company classifies its investments as available-for-sale in accordance with Statement of Financial Accounting Standards ("SFAS") No. 115, Accounting for Certain Investments in Debt and Equity Securities ("SFAS 115"). Investments in marketable securities are comprised of U.S. treasury securities and obligations of U.S. government agencies, municipal notes and bonds, corporate debt securities and other investments. Investments are recorded at fair value. Unrealized gains and losses, net of tax, on investments are included in accumulated other comprehensive income and reported as a separate component of stockholders' equity.

Investments in Other Companies

        The Company has made several investments in small, privately held technology companies in which the Company holds less than 20% of the capital stock and does not have significant influence. The Company accounts for these investments using the cost method. The Company monitors these investments for impairment and makes appropriate reductions in carrying value when an other-than-temporary decline is evident.

6



Reclassifications

        Where necessary, prior period amounts have been reclassified to conform to the current period presentation.

Stock-Based Compensation

        The Company accounts for compensation cost related to employee stock options and other forms of employee stock-based compensation plans other than the ESOP in accordance with the provisions of Accounting Principles Board ("APB") Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations. As such, compensation expense would be recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price of the award. In accordance with SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS 123"), the Company provides pro forma net income (loss) and pro forma earnings per share disclosures for employee stock option grants as if the fair-value-based method defined in SFAS 123 had been applied.

        The fair value of each stock-based compensation award is estimated on the date of grant using the Black-Scholes option-pricing model assuming no dividend yield. Had the Company determined compensation cost based on the fair value at the date of grant for its stock based compensation awards under SFAS No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure-an amendment of FASB Statement No. 123 ("SFAS 148"), the Company's net income (loss) would have been adjusted to the pro forma amounts indicated below:

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2003
  2002
  2003
  2002
 
Net income (loss) as reported   $ (59,560 ) $ 2,423   $ (76,075 ) $ 235  

Deduct: Total stock-based employee compensation expense determined under fair value based methods for all awards, net of tax

 

 

(12,107

)

 

(14,063

)

 

(26,655

)

 

(28,126

)
   
 
 
 
 
Pro forma net loss   $ (71,667 ) $ (11,640 ) $ (102,730 ) $ (27,891 )
   
 
 
 
 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic and diluted—as reported   $ (0.45 ) $ 0.02   $ (0.57 ) $ 0.00  
  Basic and diluted—pro forma   $ (0.54 ) $ (0.09 ) $ (0.77 ) $ (0.21 )

        2.    Business Combinations    

Infineon Technologies AG GaAs Business

        On July 1, 2002, the Company completed the acquisition of the GaAs Business of Infineon Technologies AG ("Infineon"). The acquisition was accounted for as a purchase transaction and the results of operations are included in the consolidated financial statements from the date of acquisition. At the closing date, the Company paid Infineon EUR50.0 million, of which EUR10.0 million represents an earnout deposit. Pursuant to the purchase agreement, Infineon may earn up to an additional EUR74.0 million over a 24-month period based upon revenues generated by the acquired business, for an aggregate purchase price of EUR124.0 million. Subsequent to the close of the acquisition, certain fixed assets were also purchased for EUR5.5 million less EUR1.5 million in funded liabilities acquired. There are also various other guarantees and contingencies which could affect the amount of the final purchase price. On October 1, 2002, the time period lapsed for the Company to reach a subsequent agreement with Infineon as to the inclusion of Infineon's Hi Rel business in the acquisition of Infineon's GaAs Business. Since an agreement was not reached, the minimum purchase price of the acquisition was adjusted to EUR42.0 million from EUR45.0 million. The Company acquired this

7



business to strengthen its European presence and to expand its market and product offerings in the wireless communications industry.

        Details of the purchase price were as follows:

Cash paid at closing   $ 53,559  
Acquisition costs     568  
Less: Earnout deposit     (9,910 )
   
 
Total purchase price   $ 44,217  
   
 

        The purchase price was allocated to the assets and liabilities based on fair values as follows:

Machinery and equipment   $ 5,440  
Identifiable intangibles     13,373  
Acquired in-process research and development     2,675  
Goodwill     24,024  
Liabilities     (1,295 )
   
 
Allocated purchase price   $ 44,217  
   
 

        In connection with this acquisition, the Company obtained a third-party valuation of the assets for purposes of the purchase price allocation. Acquired in-process research and development ("IPR&D") assets were expensed at the date of acquisition in accordance with FASB Interpretation No. 4 ("FIN 4"), Applicability of FASB Statement No. 2 to Business Combinations Accounted for by the Purchase Method. The value assigned to IPR&D related to research projects for which technological feasibility had not been established and no future alternative uses existed. The fair value was determined using the income approach, which discounts expected future cash flows from projects under development to their net present value using a risk adjusted rate. Each project was analyzed to determine the following: the technological innovations included; the utilization of core technology; the complexity, cost and time to complete development; any alternative future use or current technological feasibility; and the stage of completion. Future cash flows were estimated based upon management's estimates of revenues expected to be generated upon completion of the projects and the beginning of commercial sales and related operating costs. The projections assume that the technologies will be successful and that the product's development and commercialization will meet management's time schedule. The discount rates utilized ranged from 25% to 50% and were based on the novelty of the technology, the risks remaining to complete each project, and the extent of the Company's familiarity with the technology. As of December 31, 2002, the Company wrote off all goodwill associated with this acquisition.

A Portion of the Assets of IBM's Wireless Phone Chipset Business

        On July 1, 2002, the Company completed the acquisition of a portion of the assets of IBM's wireless phone chipset business. The acquisition was accounted for as a purchase transaction and the results of operations are included in the consolidated financial statements from the date of acquisition. At the closing date, the Company paid $21.8 million to IBM for the related assets, of which $5.0 million represents an earnout deposit. Subsequent adjustments to the purchase price contingent upon business volumes could increase the final aggregate purchase price up to $40.0 million. The Company acquired this business to expand its market and product offerings in the wireless communications industry and to strengthen its capabilities in silicon germanium process technology.

8



        Details of the purchase price are as follows:

Cash paid at closing   $ 21,750  
Acquisition costs     1,661  
Less: Earnout deposit     (5,000 )
   
 
Total purchase price   $ 18,411  
   
 

        The purchase price was allocated to the assets and liabilities based on fair values as follows:

Machinery and equipment   $ 1,959
Technology licenses     1,635
Acquired in-process research and development     5,900
Current technology     1,077
Backlog     158
Goodwill     7,682
   
Allocated purchase price   $ 18,411
   

        In connection with this acquisition, the Company obtained a third-party valuation of the assets for purposes of the purchase price allocation. Acquired IPR&D assets were expensed at the date of acquisition in accordance with FIN 4. The value assigned to IPR&D related to research projects for which technological feasibility had not been established and no future alternative uses existed. The fair value was determined using the income approach, which discounts expected future cash flows from projects under development to their net present value using a risk adjusted rate. Each project was analyzed to determine the following: the technological innovations included; the utilization of core technology; the complexity, cost and time to complete development; any alternative future use or current technological feasibility; and the stage of completion. Future cash flows were estimated based upon management's estimates of revenues expected to be generated upon completion of the projects and the beginning of commercial sales and related operating costs. The projections assume that the technologies will be successful and that the product's development and commercialization will meet management's time schedule. The discount rate utilized was 29% and was based on the novelty of the technology, the risks remaining to complete each project, and the extent of the Company's familiarity with the technology. As of December 31, 2002, the Company wrote off all goodwill and intangible assets associated with this acquisition.

        In a transaction related to this acquisition, the Company transferred $1.3 million of the acquired machinery and equipment, $1.0 million of the technology licenses, $733 of acquired workforce and $11.0 million in cash to a privately held technology company in exchange for a note receivable of $14.0 million.

        Pro forma results of operations have not been presented for this acquisition because its effects were not material on either an individual or aggregate basis.

Agere's Optoelectronics Business

        On January 2, 2003, the Company completed an acquisition of a substantial portion of the optoelectronics business of Agere Systems Inc. ("Agere") for $40 million in cash plus acquisition costs and certain assumed liabilities. The Company initially paid $35 million on January 2, 2003 and paid the balance of $5 million on April 1, 2003 to complete the purchase. The transaction included the products, technology and some facilities related to Agere's optoelectronics business, which includes active and passive components, amplifiers, transceivers, transponders and other products. As part of the acquisition, the Company has also assumed operation of the back-end assembly and test operations associated with these components at a leased facility in Matamoros, Mexico.

9



        The Company acquired this business to expand its market and product offerings in its optical networks business. Through a transition services agreement, Agere provided some business infrastructure services to the Company for a short period following the close of the transaction to ensure seamless transition of the business operations. On May 6, 2003, the Company sold a portion of the assets acquired in this transaction for $6.6 million in cash.

        Details of the purchase price were as follows:

Cash paid at closing   $ 35,000
Deferred cash payment     5,000
Acquisition costs     200
   
Total purchase price   $ 40,200
   

        The purchase price was allocated to the assets and liabilities based on fair values as follows:

Inventory   $ 12,000  
Other assets     12,000  
Property, plant and equipment     36,271  
Identifiable intangibles     2,178  
Acquired in-process research and development     500  
Liabilities     (22,749 )
   
 
Allocated purchase price   $ 40,200  
   
 

        In connection with this acquisition, the Company obtained a third-party valuation of some of the assets for purposes of the purchase price allocation. Acquired IPR&D assets were expensed at the date of acquisition in accordance with FIN 4. The value assigned to IPR&D related to research projects for which technological feasibility had not been established and no future alternative uses existed. The fair value was determined using the income approach, which discounts expected future cash flows from projects under development to their net present value using a risk adjusted rate. The project was analyzed to determine the following: the technological innovations included; the utilization of core technology; the complexity, cost and time to complete development; any alternative future use or current technological feasibility; and the stage of completion. Future cash flows were estimated based upon management's estimates of revenues expected to be generated upon completion of the projects and the beginning of commercial sales and related operating costs. The projections assume that the technologies will be successful and that the product's development and commercialization will meet management's time schedule. The discount rate was 35% and was based on the novelty of the technology, the risks remaining to complete each project, and the extent of the Company's familiarity with the technology.

        Pro forma results of operations as if the Infineon and Agere acquisitions had closed on January 1, 2002 are as follows:

 
  Pro Forma
 
 
  Three Months
Ended
June 30,
2002

  Six Months
Ended
June 30,
2002

 
Revenues   $ 124,985   $ 251,089  
Net loss     (56,665 )   (117,940 )
Loss per share—basic and diluted   $ (0.43 ) $ (0.90 )

10


        3.    Segment Information    

        SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information ("SFAS 131") establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas and major customers. The method for determining what information to report is based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company has aggregated its businesses into a single reportable segment as allowed under SFAS 131 because the segments have similar long-term economic characteristics. In addition, the segments are similar in regards to (a) nature of products and production processes, (b) type of customers and (c) method used to distribute products. Accordingly, the Company describes its reportable segment as high-performance components and modules for communications applications. All of the Company's revenues result from sales in its product lines.

        Our sales outside of the United States were 59% and 58% of revenues for the three and six months ended June 30, 2003, respectively, and 53% and 54% of revenues for the three and six months ended June 30, 2002, respectively.

        4.    Net Income (Loss) Per Share    

        Net income (loss) per share is presented as basic and diluted net income (loss) per share. Basic net income (loss) per share is net income (loss) available to common stockholders divided by the weighted-average number of common shares outstanding. Diluted net income (loss) per share is similar to basic except that the denominator includes potential common shares that, had they been issued, would have had a dilutive effect.

        The following is a reconciliation of the basic and diluted shares:

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
  2003
  2002
  2003
  2002
Shares for basic net income (loss) per share:                
  Weighted-average common shares   133,554,233   131,656,161   133,374,070   131,470,021
Effect of dilutive securities:                
  Stock options     3,187,831     3,421,593
   
 
 
 
Shares for dilutive net income (loss) per share:   133,554,233   134,843,992   133,374,070   134,891,614
   
 
 
 

        Stock options and other exer